Fig 3.

Flare on bone scan. Two new lesions at 8 weeks were not followed by subsequent additional lesions, so patient remained on study; bone scan markedly improved over 18 months. POD, progression of disease; PSA, prostate-specific antigen; RECIST, Response Evaluation Criteria in Solid Tumors.